The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin end ghrelin on polycystic ovary syndrome

Özet

Objective: To evaluate short-term leptin and ghrelin concentrations in women with polycystic ovary syndrome (PCOS) who use low-dose oral contraceptives containing drospirenone. Design: Prospective study. Setting: Department of obstetrics and gynaecology in a university hospital. Patient(s): Twenty women with PCOS were enrolled in the study. Intervention(s): A low-dose oral contraceptive containing ethinyl estradiol and drospirenone was given for three cycles. Main Outcome Measure(s): Serum androstenedione, free T, T, dehydroepiandrosterone sulphate, sex hormone-binding globulin, FSH, LH, E-2, lipid profiles, leptin, and ghrelin levels were measured in each subject. Insulin resistance was estimated by the homeostasis model assessment-insulin resistance (HOMA-IR). Result(s): While leptin concentrations did not change with therapy, ghrelin levels increased statistically. Baseline leptin concentrations were correlated positively with body mass index, waist-to-hip ratio, insulin, and HOMA-IR and negatively with ghrelin. After controlling for body mass index and waist-to-hip ratio in a partial correlation analysis, leptin levels were not correlated with these parameters. Ghrelin was inversely correlated with body mass index, waist-to-hip ratio, insulin, HOMA-IR, and free T. Conclusion(s): In patients with PCOS, an oral contraceptive containing ethinyl estradiol and drospirenone increases ghrelin levels but not leptin levels in a 3-month period. Ghrelin might be related to the metabolic and androgenic changes in patients with PCOS. (Fertil Steril (R) 2009;92:660-6. (C)2009 by American Society for Reproductive Medicine.)

Açıklama

Yucel, Aykan/0000-0002-5888-692X

Anahtar Kelimeler

PCOS, leptin, ghrelin, drospirenone, oral contraceptive

Kaynak

Fertility And Sterility

WoS Q Değeri

Q1

Scopus Q Değeri

Q1

Cilt

92

Sayı

2

Künye

closedAccess